MarketCap
Facebook
X
Telegram
bluebird bio Income Statement 2024-2010 | BLUE
Brief overview of revenue and earnings at bluebird bio
The figures are compared over a five-year interval. bluebird bio reported revenue of $44.7 million in 2019 and $83.8 million by 2024. The cumulative result was +87.6%, corresponding to roughly 13.4% per year. The pace indicates confident and sustained business growth.
The gross result shifted from $41.7 million to −$5.6 million, or −113.4%. Costs absorbed a larger share of revenue over the period. The gross margin was 93.3% at the start and −6.6% at the end. The margin decline reflects a less favorable sales-and-cost structure.
EBITDA was −$795 million at the beginning and −$210 million at the end of the period (+73.6%). Changes in revenue did not translate into comparable EBITDA performance. Comparing the endpoints gives EBITDA margins of −1778.8% and −250.8%. The company improved its ability to convert sales into EBITDA.
Comparing the endpoints shows a move from −$790 million to −$241 million. The loss reduction is constructive, but the recovery is incomplete.
What the figures show
The results contain several connected negative signals. The strongest signals are a larger revenue base, improving net profitability and positive operating leverage. The overall view is constrained by limited operating profitability, weaker gross profitability and a low gross margin. The key question is whether sales can be converted into sustainable profit.
Annual Income Statement bluebird bio
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
- | 3.35 M | 354 M | 416 M | 1.25 B | 4.54 B | 6.77 B | 8.87 B | 2.56 B | 1.43 B | 2.47 B | 280 M | - | - | - |
Shares |
9.69 M | 5.49 M | 78.6 M | 68.9 M | 62.2 M | 55.2 M | 52 M | 43.5 M | 37.3 M | 34.7 M | 26.5 M | 12.6 M | - | - | - |
Historical Prices |
- | 0.61 | 4.51 | 6.04 | 20.1 | 46.8 | 101 | 130 | 56.8 | 29.9 | 61.7 | 16.5 | - | - | - |
Net Income |
-241 M | -212 M | -230 M | -819 M | -619 M | -790 M | -556 M | -336 M | -264 M | -167 M | -48.7 M | -25.3 M | -23.7 M | -15.6 M | - |
Revenue |
83.8 M | 29.5 M | 3.6 M | 3.66 M | 251 M | 44.7 M | 54.6 M | 35.4 M | 6.16 M | 14.1 M | 25.4 M | 20.2 M | 340 K | 882 K | - |
Cost of Revenue |
89.4 M | 33.5 M | 10.1 M | - | - | 2.98 M | 885 K | 1.53 M | - | - | - | - | - | - | - |
Gross Profit |
-5.57 M | -4.03 M | -6.48 M | - | - | 41.7 M | 53.7 M | 33.9 M | - | - | - | - | - | - | - |
Operating Income |
-270 M | -244 M | -250 M | -591 M | -559 M | -563 M | -572 M | -332 M | -268 M | -169 M | -60.6 M | -24.9 M | -23.7 M | -15.1 M | - |
Interest Expense |
44.2 M | 38.7 M | 6.32 M | 27.7 M | -6.88 M | -9.98 M | 1.96 M | -1.27 M | -71 K | 723 K | 120 K | -403 K | 46 K | -456 K | - |
EBITDA |
-210 M | -216 M | -242 M | -586 M | -554 M | -795 M | -552 M | -319 M | -254 M | -159 M | -56.2 M | -24 M | -23.4 M | -14.9 M | - |
Operating Expenses |
- | - | - | - | - | 854 M | 623 M | 367 M | 270 M | 180 M | 85.8 M | 45.1 M | 24.1 M | 16 M | - |
General and Administrative Expenses |
168 M | 166 M | 140 M | 210 M | 240 M | 271 M | 174 M | 93.6 M | 65.1 M | 46.2 M | 23.2 M | 14.1 M | 6.85 M | 4.62 M | - |
All numbers in USD currency
Quarterly Income Statement bluebird bio
| 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
9.75 M | 9.73 M | 194 M | 194 M | 9.66 M | 193 M | 109 M | 109 M | 103 M | 82.9 M | 81.5 M | 73.8 M | 73.7 M | 71.1 M | 68.6 M | 67.5 M | 67 M | 66.4 M | 66.3 M | 60.4 M | 55.6 M | 55.4 M | 55.3 M | 55.2 M | 55 M | 54.7 M | 53.3 M | 50.2 M | 49.9 M | 49.4 M | 45.6 M | 41 M | 40.8 M | 40.7 M | 37.2 M | 37 M | 36.9 M | 36.9 M | 36.4 M | 33 M | 32.6 M | 32.3 M | 28.1 M | 24.5 M | 24.1 M | 23.9 M | 23.6 M | 2.15 M | 328 K | 309 K | 275 K | 252 K | - | - | - | - | - |
Net Income |
-29.1 M | - | -60.8 M | -81.4 M | -69.8 M | - | -87.2 M | -62.8 M | 18.9 M | - | -76.5 M | -100 M | -122 M | -155 M | -217 M | -242 M | -206 M | -200 M | -195 M | -21.5 M | -203 M | -223 M | -206 M | -196 M | -164 M | -149 M | -145 M | -146 M | -115 M | -117 M | -78.8 M | -70.9 M | -68.7 M | -71.4 M | -77 M | -58.8 M | -56.3 M | -47.3 M | -42.9 M | -51.8 M | -24.8 M | -19.5 M | -17 M | -1.53 M | -10.6 M | -8.08 M | -6.11 M | -4.58 M | -6.54 M | -9 M | -5.04 M | -4.56 M | -5.07 M | - | - | - | - |
Revenue |
38.7 M | - | 10.6 M | 16.1 M | 18.6 M | - | 12.4 M | 6.89 M | 2.38 M | - | 71 K | 1.52 M | 1.94 M | 1.61 M | 1.02 M | 143 K | 894 K | - | - | - | - | 10 M | 8.91 M | 13.3 M | 12.5 M | 19.2 M | 11.5 M | 7.85 M | 16 M | 4.17 M | 7.71 M | 16.7 M | 6.83 M | 1.55 M | 1.55 M | 1.55 M | 1.5 M | 1.47 M | 1.32 M | 4.94 M | 6.34 M | 6.39 M | 6.36 M | 6.34 M | 6.34 M | 6.34 M | 6.38 M | 6.33 M | 1.13 M | 85 K | 85 K | 85 K | 85 K | - | - | - | - |
Cost of Revenue |
12.2 M | - | 11.8 M | 28.9 M | 25.9 M | - | 9.13 M | 6.7 M | 5.51 M | - | - | 1.74 M | 8.31 M | - | 19.4 M | 15.3 M | 576 K | - | 1.32 M | 1.55 M | 1.02 M | - | 862 K | 613 K | 430 K | - | 29 K | 21 K | 17 K | - | 1.1 M | 420 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
26.5 M | - | -1.17 M | -12.8 M | -7.29 M | - | 3.27 M | 193 K | -3.13 M | - | 71 K | -226 K | -6.36 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-24.6 M | - | -66.9 M | -88.4 M | -78.7 M | - | -96 M | -71.7 M | 10.7 M | - | -84.8 M | -107 M | -120 M | -136 M | -154 M | -155 M | -146 M | -139 M | -132 M | -144 M | -144 M | -231 M | -210 M | -203 M | -171 M | -157 M | -150 M | -149 M | -117 M | -117 M | -77.7 M | -67.8 M | -69.9 M | -72.3 M | -78.1 M | -60 M | -57.4 M | -49 M | -43.1 M | -52 M | -24.9 M | -19.6 M | -17 M | -13.3 M | -10.7 M | -8.12 M | -6.16 M | -4.19 M | -6.48 M | -8.96 M | -5.02 M | -4.6 M | -5.14 M | - | - | - | - |
Interest Expense |
769 K | - | 10.2 M | 9.64 M | 11.2 M | - | 4.31 M | 3.75 M | 4.27 M | - | 7.88 M | 7.09 M | -1.91 M | - | 1.34 M | -1.09 M | 24.3 M | - | -6.69 M | 1.55 M | -4.45 M | - | -4.3 M | -2.94 M | -3.39 M | - | -252 K | 182 K | 115 K | - | 8 K | -834 K | -355 K | - | 937 K | -76 K | 961 K | - | 263 K | 228 K | 139 K | - | -20 K | 11 K | 59 K | - | 44 K | -389 K | -63 K | - | -17 K | 37 K | - | - | - | - | - |
EBITDA |
-9.06 M | - | - | - | -63.2 M | - | - | - | 16.9 M | - | -81 M | -107 M | -119 M | -136 M | -137 M | -155 M | -141 M | -139 M | -117 M | -134 M | -140 M | -231 M | -198 M | -195 M | -167 M | -157 M | -137 M | -140 M | -113 M | -117 M | -67.8 M | -61.5 M | -67.1 M | -72.3 M | -71 M | -55.2 M | -55.1 M | -49 M | -37.7 M | -48.5 M | -23.2 M | -19.6 M | -14.5 M | -12.3 M | -10.2 M | -8.12 M | -5.55 M | -3.89 M | -6.34 M | -8.96 M | -4.82 M | -4.47 M | -5.14 M | - | - | - | - |
Operating Expenses |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 176 M | 161 M | 156 M | 133 M | 121 M | 85.4 M | 84.5 M | 76.7 M | 73.9 M | 79.7 M | 61.5 M | 58.9 M | 50.4 M | 44.5 M | 57 M | 31.3 M | 26 M | 23.4 M | 19.7 M | 17 M | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
30.3 M | - | 39.8 M | 50.4 M | 46.3 M | - | 40.8 M | 40.5 M | 37.5 M | - | 33.4 M | 36.7 M | 36.1 M | - | 42.2 M | 78.6 M | 63.6 M | - | 68 M | 68.6 M | 73.2 M | - | 66.2 M | 68.6 M | 60.3 M | - | 44.5 M | 41.2 M | 34.9 M | - | 23 M | 21.2 M | 20.3 M | - | 14.6 M | 18.4 M | 16 M | - | 13.7 M | 10.7 M | 7.34 M | - | 6.65 M | 5.74 M | 5.54 M | - | 3.84 M | 3.28 M | 2.32 M | - | 1.61 M | 1.33 M | - | - | - | - | - |
All numbers in USD currency
The income statement is one of the three key financial reports of a company bluebird bio (alongside the balance sheet and the cash flow statement). It shows how the company makes money and what its expenses are:
- How much revenue the company earned
- How much it spent on production, personnel, marketing, taxes, etc.
- What profit remained in the end
Analyzing the income statement helps an investor understand whether the business generates stable and growing profits, how effectively the company controls its expenses, and whether it is capable of generating income in the future. Additionally, this analysis shows how the company copes with crises and economic cycles, and allows assessing the potential for stock price growth and dividend payments.
Features- The income statement may include both recurring and one-time items (for example, profit from the sale of assets). It is necessary to separate core metrics from one-off events for accurate analysis.
- Companies often publish interim reports (e.g., quarterly), which allows for more timely tracking of trends.
- A combined analysis of the income statement with the balance sheet and cash flow statement provides a comprehensive view of the company’s financial health.
USA
Canada
China
Israel
France
Germany
Britain
Russia
Belgium
Cayman-islands
